Ontology highlight
ABSTRACT:
SUBMITTER: Stary G
PROVIDER: S-EPMC2118597 | biostudies-literature | 2007 Jun
REPOSITORIES: biostudies-literature
Stary Georg G Bangert Christine C Tauber Martina M Strohal Robert R Kopp Tamara T Stingl Georg G
The Journal of experimental medicine 20070529 6
Imiquimod (IMQ), a synthetic agonist to Toll-like receptor (TLR) 7, is being successfully used for the treatment of certain skin neoplasms, but the exact mechanisms by which this compound induces tumor regression are not yet understood. While treating basal cell carcinoma (BCC) patients with topical IMQ, we detected, by immunohistochemistry, sizable numbers of both myeloid dendritic cells (mDCs) and plasmacytoid DCs (pDCs) within the inflammatory infiltrate. Surprisingly, peritumoral mDCs staine ...[more]